Improving the prognosis of patients after radical cystectomy. Part II: The role of perioperative chemotherapy

BJU International

Volumn 100, Issue 6, 2007, Pages 1225-1228

  Suttmann, Henrik ^a   Kamradt, Jörn ^a   Lehmann, Jan ^b   Stöckle, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE

Author keywords

Bladder cancer; Dilution effect; Nonresponder effect; Perioperative chemotherapy; Radical cystectomy

Indexed keywords

CISPLATIN;

ADJUVANT CHEMOTHERAPY; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; DISEASE COURSE; HIGH RISK PATIENT; HUMAN; MULTIMODALITY CANCER THERAPY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; HUMANS; PERIOPERATIVE CARE; PROGNOSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 35748932332     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07113.x     Document Type: Short Survey

References (20)

1. Sternberg CN, Yagoda A, Scher HI et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985 133 : 403 7
2. Oosterlinck W, Lobel B, Jakse G, Malmström PU, Stöckle M, Sternberg CN. Guidelines on bladder cancer. Eur Urol 2002 41 : 105 12
3. von der Maase H, Hansen SW, Roberts JT et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000 18 : 3068 77
4. Schoenfeld D. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 1981 68 : 316 9
5. Advanced Bladder Cancer Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer. a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005 48 : 189 201
6. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer. update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005 48 : 202 5
7. Gommersall LM, Arya M, Mushtaq I, Duffy P. Current challenges in Wilms' tumor management. Nat Clin Pract Oncol 2005 2 : 298 304
8. Bassi P, Pappagallo GL, Sperandio P et al. Neoadjuvant M-VAC chemotherapy of invasive bladder cancer: Results of a Multicenter Phase III Trial. J Urol 1999 161 (Suppl. A1021
9. Lee CT, Madii R, Daignault S et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 2006 175 : 1262 7
10. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer. a systematic review and meta-analysis. Lancet 2003 361 : 1927 34
11. Stadler WM, Lerner SP. Perioperative chemotherapy in locally advanced bladder cancer. Lancet 2003 361 : 1922 3
12. Stöckle M, Meyenburg W, Wellek S et al. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 1995 153 : 47 52
13. Freiha FS, Reese JH, Torti FM. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 1996 155 : 495 500
14. Skinner DG, Daniels JR, Russell CA et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991 145 : 459 64
15. Studer UE, Bacchi M, Biedermann C et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer. results of a prospective randomized trial. J Urol 1994 152 : 81 4
16. Bono AV, Benvenuti C, Reali L et al. Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group. Prog Clin Biol Res 1989 303 : 533 40
17. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001 19 : 666 75
18. Lehmann J, Retz M, Wiemers C et al. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). J Clin Oncol 2005 23 : 4963 74
19. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 2005 23 : 2358 65
20. Gschwend JE, Volkmer BG, Hautmann RE. Radical cystectomy for bladder cancer in the neobladder era - progression and survival in 674 consecutive patients. J Urol 2004 171 (Suppl. A80